Related Experiment Video

Updated: May 10, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

Editorial: Metabolomics in personalized cancer medicine

Joana Pinto1,2, Jacopo Troisi3,4,5

  • 1Associate Laboratory i4HB-Institute for Health and Bioeconomy, University of Porto, Porto, Portugal.

Frontiers in Molecular Biosciences
|April 23, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
biomarkercancerevidence based medecinemetabolomicspersonalized medicinepersonalized oncology

More Related Videos

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.0K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

Related Experiment Videos

Last Updated: May 10, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.0K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

Articles linked to this work by shared authors, journal, and citation graph.

Quantitative analysis of toxic metals in plasma and intracranial thrombi in acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026

Maternal Nutritional Adherence and Second-Trimester Amniotic-Fluid Metabolomic Profiles: An Exploratory Study.

Medicina (Kaunas, Lithuania)·2026

Transient Middle Cerebral Artery Occlusion in Rats as a Nonclinical Model of Ischemic Stroke: A Systematic Review.

Current issues in molecular biology·2026

Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies.

Journal of proteome research·2026

Metabolomic signatures supporting clinical stratification of Parkinson disease and atypical parkinsonism.

Parkinsonism & related disorders·2026

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

EMBO molecular medicine·2026

Late-onset mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes with chronic intestinal pseudo-obstruction: a case-based review.

Frontiers in molecular biosciences·2026

Serum vitamins and microelements levels and their association with children with attention deficit hyperactivity disorder (ADHD).

Frontiers in molecular biosciences·2026

Regulation of TMEM2-mediated hyaluronan degradation by CD44 and LYVE-1.

Frontiers in molecular biosciences·2026

EMCN is associated with vascular-immune crosstalk and represents a potential biomarker in lung adenocarcinoma.

Frontiers in molecular biosciences·2026

Adaptive-to-maladaptive IRE1α signaling as a driver of amyloidogenic APP processing in Alzheimer's disease.

Frontiers in molecular biosciences·2026

Exploring the toxicity of extracts, fractions, and their bioactive components from raw and roasted sea buckthorn seeds on selected human cells.

Frontiers in molecular biosciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us